CLEVELAND, June 1, 2012 /PRNewswire/ -- In a recently published article, "Decontamination with Ultraviolet Radiation to Prevent Recurrent Clostridium difficile Infection in 2 Roommates

SAN DIEGO, June 1, 2012 /PRNewswire/ -- Optimer Pharmaceuticals, Inc.

ORANGEBURG, N.Y., May 30, 2012 /PRNewswire/ -- PDI, the leader in infection prevention education, support, and products in healthcare settings,

EXTON, Pa., May 22, 2012 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that Charles Rowland, vice president and chief financial officer of ViroPharma, will present at

A study presented by Mayo Clinic researchers during Digestive Disease Week 2012 provides clear evidence that the number of people contracting the hard-to-control and treat bacterial infection Clostridium difficile (C. difficile or C. diff) is increasing, and that the infection is commonly contracted outside of the hospital.